Home > Insider Trading > Filing (0001628280-25-007693)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1706431	Vir Biotechnology Inc.	VIR	Biological Products, (No Disgnostic Substances) (2836)	812730369

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1797819	Marianne Backer De	C/O Vir Biotechnology, Inc. 1800 Owens Street, Suite 900 San Francisco CA 94158	Chief Executive Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2025-02-22	240,000	$0.00	865,339	No	4	A	Direct
Common Stock	Disposition	2025-02-24	16,122	$9.45	849,217	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	A	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Acquisiton	2025-02-22	480,000	$0.00	480,000	$9.57

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
480,000		2035-02-21	No	4	A	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	53,118	Indirect	See Footnote

Footnotes

Acquisition of restricted stock units pursuant to the Issuer's Equity Incentive Plan.
Represents the automatic sale of shares to cover the Issuer's tax withholding and remittance obligation in connection with the vesting of restricted stock units.
The shares are held in the name of the Ureel-De Backer Family Trust, of which the reporting person and her spouse are Trustees.
25% of the shares subject to the stock option vest and become exercisable on February 22, 2026, and the remaining shares vest in 36 equal monthly installments thereafter.